Jupiter Life Line Hospitals Q2: revenue up 16% YoY to ₹456.50 Cr as EBITDA reaches ₹106.85 Cr
The company is a healthcare provider operating multi-speciality hospitals in India. Its network includes facilities in Thane, Pune, Indore and Dombivli. The company focuses on specialised medical services, advanced treatment facilities and expanding its hospital capacity to cater to growing healthcare demand.
The Nifty 50 traded at 22,592.00, down by 0.08%, while the Sensex gained to 73,154.89, up by 0.042% on Monday. The shares of Jupiter Life Line Hospitals are currently trading at Rs. 255.20, up by 4.67%. The company has a market capitalisation of Rs. 8,376.06 crore. The stock’s 52 week high is Rs. 340.00 and its 52 week low is Rs. 233.40. In the past 6 months the stock has delivered a return of Rs. 0.78%.
Also Read: Ramky Infrastructure bags ₹588.57 Cr EPC contract from RVNL for NMDC township residential project in Chhattisgarh
What’s the News?
Jupiter Life Line Hospitals reported its consolidated Q2 FY27 results for the quarter ended September 2026, with revenue from operations increasing 16% year-on-year to Rs. 456.50 crore from Rs. 393.63 crore in Q2 FY26.
EBITDA rose 15.8% to approximately Rs. 106.85 crore from Rs. 92.25 crore. However, net profit declined 2.1% to Rs. 56.17 crore compared with Rs. 57.35 crore in the corresponding quarter last year. The results reflect healthy business growth, although higher costs below the operating profit level affected the conversion of operating earnings into net profit.
Q2 FY27 Financial Performance
Looking at the quarterly results of Jupiter Life Line Hospitals Limited, consolidated revenue from operations increased 16% year-on-year to Rs. 456.50 crore. The growth indicates continued expansion in the company's hospital business and higher revenue generation compared with the same quarter last year.
Operating performance also remained positive, with EBITDA increasing 15.8% to Rs. 106.85 crore from Rs. 92.25 crore. The EBITDA margin stood at approximately 23.4%, broadly unchanged from the year-ago period. This suggests that the company maintained its operating profitability while expanding revenue.
However, net profit declined 2.1% to Rs. 56.17 crore from Rs. 57.35 crore. Profit before tax increased only marginally to Rs. 75.08 crore from Rs. 74.22 crore, as higher depreciation and finance costs offset a significant part of the improvement in operating earnings.
Why Did Net Profit Decline Despite Revenue Growth?
The key factor behind the weaker net profit was the increase in expenses below operating profit. Depreciation expenses rose approximately 32.7% year-on-year to Rs. 28.48 crore, while finance costs increased around 76.5% to Rs. 13.83 crore.
These increases reduced the benefit of higher operating earnings. The rise in depreciation may reflect the company's hospital infrastructure and asset base, while higher finance costs added to the burden on earnings. However, the reported figures alone do not establish the precise contribution of each factor to the increase.
Employee expenses also increased approximately 28.6% to Rs. 81.33 crore from Rs. 63.25 crore, outpacing revenue growth. This is an important metric to monitor as the company expands its capacity and manages staffing requirements across its hospitals.
Hospital Expansion and Operating Performance
The performance of the company's existing hospitals and the ramp-up of newer facilities will remain important for future growth. During the Q2 FY27 earnings call, management highlighted progress at the Dombivli hospital, where the EBITDA loss narrowed sharply to approximately Rs. 20 lakh from Rs. 9.5 crore in Q1 FY27.
Management also indicated that the Dombivli facility's insurance empanelment process was ongoing. The hospital's ability to attract patients, improve occupancy and move towards operational profitability will be important to monitor as the facility matures.
The company reported overall occupancy of 59.5% during the quarter, increasing to 64.8% when Dombivli was excluded. Management also noted that the Thane and Pune hospitals were operating at around 70% occupancy, highlighting the importance of capacity utilisation and future expansion planning.
Key Factors to Watch
Going forward, investors should monitor whether revenue growth translates into stronger net profit. Stable EBITDA margins are encouraging, but the rise in depreciation, finance costs and employee expenses remains a key consideration.
The ramp-up of the Dombivli hospital, occupancy levels at existing facilities, and the pace at which newer capacity contributes to earnings will also influence future performance. If the company improves utilisation while managing operating and financing costs, profitability could benefit. However, the timing and extent of such improvement remain uncertain.